Finance entity
markets is the sole category represented across all 1 tracked stories. Argus Research is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline.
Last mentioned: 5h ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. Argus Research is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. At 6, the average consequence score sits below the same-window beat average of 6.3. We currently track 1 Finance story that mention EVX-B3, all published on August 22, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering EVX-B3. Shared-story counts are live from our verified record — not editorial picks.
Argus raised Merck's price target to $145 on pipeline depth and M&A, while Merck disclosed a small strategic stake in Evaxion. For investors, the story is the huge gap between a mega-cap's $16.6 billion quarter and a micro-cap's cash-burning AI bet.
EVX-B3 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
